Find Your Funding Opportunity
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
01-07-2028 | $500,000 | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Opportunity Type Discretionary
-
CFDA
93.242 -- Mental Health Research Grants
93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
93.855 -- Allergy and Infectious Diseases Research
93.865 -- Child Health and Human Development Extramural Research
Description
The purpose of this notice of funding opportunity (NOFO) is to support research to define the impact of defective HIV proviruses on mechanisms of HIV persistence and pathogenesis during antiretroviral treatment and their potential deleterious effects on HIV cure strategies and interference with HIV-specific molecular assays.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Key Date(s)
- December 09, 2024: Last Updated Date
- December 09, 2024: Posted Date
- January 07, 2028: Current Closing Date for Applications
- January 07, 2028: Application Due Date
- February 12, 2028: Application Archive Date
Contact Information
NIH Grants Information
grantsinfo@nih.gov